Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Retained Earnings (2019 - 2025)

Historic Retained Earnings for Legend Biotech (LEGN) over the last 7 years, with Q3 2025 value amounting to $1.0 billion.

  • Legend Biotech's Retained Earnings fell 939.43% to $1.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year decrease of 939.43%. This contributed to the annual value of $1.0 billion for FY2024, which is 1684.81% down from last year.
  • As of Q3 2025, Legend Biotech's Retained Earnings stood at $1.0 billion, which was down 939.43% from $1.0 billion recorded in Q2 2025.
  • Legend Biotech's Retained Earnings' 5-year high stood at $1.4 billion during Q2 2023, with a 5-year trough of $206424.0 in Q1 2021.
  • Moreover, its 5-year median value for Retained Earnings was $1.0 billion (2025), whereas its average is $849.8 million.
  • As far as peak fluctuations go, Legend Biotech's Retained Earnings surged by 35893238.0% in 2022, and later plummeted by 1762.83% in 2024.
  • Over the past 5 years, Legend Biotech's Retained Earnings (Quarter) stood at $766.0 million in 2021, then decreased by 2.87% to $744.0 million in 2022, then soared by 68.19% to $1.3 billion in 2023, then dropped by 16.85% to $1.0 billion in 2024, then dropped by 2.81% to $1.0 billion in 2025.
  • Its last three reported values are $1.0 billion in Q3 2025, $1.0 billion for Q2 2025, and $1.0 billion during Q1 2025.